Here We Go: Pfizer and BioNTech Begin Phase 1 Study of Combined mRNA-Based Vaccine for COVID-19 and Influenza
On Thursday, U.S. pharmaceutical giant Pfizer Inc. and its German partner BioNTech announced the launch of Phase I clinical trial to assess the efficacy of a combination vaccination targeting COVID-19 and influenza. The single-dose vaccination candid
